Stocks
CytoDyn Inc.CYDY
OQBHealthcareBiotechnology$0.26
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing leronlimab, a monoclonal antibody candidate for HIV and other conditions. Its pipeline has faced regulatory setbacks and funding challenges, making it a high-risk, high-attention stock among retail investors.
52W Range: $0.18-$0.40
Congressional Interest in CytoDyn Inc. (CYDY)
No congressional trades have been disclosed for CytoDyn Inc. (CYDY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CYDY?
No congressional trades found for this stock.